Endothelial Progenitor Cells for Cardiovascular Regeneration

Trends in Cardiovascular Medicine

Volumn 18, Issue 1, 2008, Pages 33-37

  Kawamoto, Atsuhiko ^a,b   Losordo, Douglas W ^c,d  

^a INSTITUTE OF BIOMEDICAL RESEARCH AND INNOVATION   (Japan)

^b RIKEN Center for Biosystems Dynamics Research   (Japan)

^c NORTHWESTERN UNIVERSITY   (United States)

^d NORTHWESTERN MEMORIAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL REGENERATION; CELL THERAPY; CORONARY ARTERY DISEASE; ENDOTHELIUM CELL; HUMAN; ISCHEMIC HEART DISEASE; NEOVASCULARIZATION (PATHOLOGY); PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVIEW; STEM CELL;

ANIMALS; BONE MARROW CELLS; CARDIOVASCULAR DISEASES; CELL CULTURE TECHNIQUES; ENDOTHELIUM, VASCULAR; HUMANS; NEOVASCULARIZATION, PHYSIOLOGIC; REGENERATION; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 38149022647     PISSN: 10501738     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tcm.2007.11.004     Document Type: Review

References (46)

1. Asahara T., Murohara T., Sullivan A., et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275 (1997) 964-967
2. Asahara T., Masuda H., Takahashi T., et al. Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization. Circ Res 85 (1999) 221-228
3. Asahara T., Takahashi T., Masuda H., et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 18 (1999) 3964-3972
4. Assmus B., Schachinger V., Teupe C., et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106 (2002) 3009-3017
5. Bartunek J., Vanderheyden M., Vandekerckhove B., et al. Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety. Circulation 112 (2005) I178-I183
6. Carmeliet P., Ferreira V., Breier G., et al. Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380 (1996) 435-439
7. Dimmeler S., Aicher A., Vasa M., et al. HMG-CoA-reductase inhibitors (statins) increase endothelial progenitor cells via the P13 kinase/Akt pathway. J Clin Invest 108 (2001) 391-397
8. Ferrara N., Carver-Moore K., Chen H., et al. Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380 (1996) 439-442
9. Flamme I., and Risau W. Induction of vasculogenesis and hematopoiesis in vitro. Development 116 (1992) 435-439
10. Gehling U.M., Ergun S., Schumacher U., et al. In vivo differentiation of endothelial cells from AC133-positive progenitor cells. Blood 95 (2000) 3106-3112
11. Gill M., Dias S., Hattori K., et al. Vascular trauma induces rapid but transient mobilization of VEGFR(+)AC133(+) endothelial precursor cells. Circ Res 88 (2001) 167-174
12. Gunsilius E., Duba H.C., Petzer A.L., et al. Evidence from a leukaemia model for maintenance of vascular endothelium by bone marrow-derived endothelial cells. Lancet 355 (2000) 1688-1691
13. His W. Leoithoblast und Angioblast der Wirbelthiere. Abhandl K S Ges Wiss Math Phys 22 (1900) 171-328
14. Hofmann M., Wollert K.C., Meyer G.P., et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation 111 (2005) 2198-2202
15. Iwasaki H., Kawamoto A., Ishikawa M., et al. Dose-dependent contribution of CD34-positive cell transplantation to concurrent vasculogenesis and cardiomyogenesis for functional regenerative recovery after myocardial infarction. Circulation 113 (2006) 1311-1325
16. Kalka C., Masuda H., Takahashi T., et al. Vascular endothelial growth factor(165) gene transfer augments circulating endothelial progenitor cells in human subjects. Circ Res 86 (2000) 1198-1202
17. Kalka C., Masuda H., Takahashi T., et al. Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization. Proc Natl Acad Sci U S A 97 (2000) 3422-3427
18. Kalka C., Tehrani H., Laudenberg B., et al. VEGF gene transfer mobilizes endothelial progenitor cells in patients with inoperable coronary disease. Ann Thorac Surg 70 (2000) 829-834
19. Kamihata H., Matsubara H., Nishiue T., et al. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104 (2001) 1046-1052
20. Kawamoto A., Gwon H.C., Iwaguro H., et al. Therapeutic potential of ex vivo expanded endothelial progenitor cells for myocardial ischemia. Circulation 103 (2001) 634-637
21. Kawamoto A., Iwasaki H., Kusano K., et al. CD34-positive cells exhibit increased potency and safety for therapeutic neovascularization after myocardial infarction compared with total mononuclear cells. Circulation 114 (2006) 2163-2169
22. Kawamoto A., Katayama M., Handa N., et al. Safety and efficacy is sustained up to one year after transplantation of autologous CD34+ cells in no-option patients with chronic critical limb ischemia. Circulation 114 18 Supplement (2006) II-264 Abstract
23. Kawamoto A., Tkebuchava T., Yamaguchi J., et al. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107 (2003) 461-468
24. Klein H.M., Ghodsizad A., Marktanner R., et al. Intramyocardial implantation of CD133+ stem cells improved cardiac function without bypass surgery. Heart Surg Forum 10 (2007) E66-E69
25. Kocher A.A., Schuster M.D., Szabolcs M.J., et al. Neovascularization of ischemic myocardium by human bone marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 7 (2001) 430-436
26. Lin Y., Weisdorf D.J., Solovey A., and Hebbel R.P. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105 (2000) 71-77
27. Llevadot J., Murasawa S., Kureishi Y., et al. HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells. J Clin Invest 108 (2001) 399-405
28. Losordo D.W., Schatz R.A., White C.J., et al. Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial. Circulation 115 (2007) 3165-3172
29. Murohara T. Therapeutic vasculogenesis using human cord blood-derived endothelial progenitors. Trends Cardiovasc Med 11 (2001) 303-307
30. Peichev M., Naiyer A.J., Pereira D., et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95 (2000) 952-958
31. Ripa R.S., Jorgensen E., Wang Y., et al. Stem cell mobilization induced by subcutaneous granulocyte-colony stimulating factor to improve cardiac regeneration after acute ST-elevation myocardial infarction: result of the double-blind, randomized, placebo-controlled stem cells in myocardial infarction (STEMMI) trial. Circulation 113 (2006) 1983-1992
32. Seiler C., Pohl T., Wustmann K., et al. Promotion of collateral growth by granulocyte-macrophage colony-stimulating factor in patients with coronary artery disease: a randomized, double-blind, placebo-controlled study. Circulation 104 (2001) 2012-2017
33. Shalaby F., Rossant J., Yamaguchi T.P., et al. Failure of blood-island formation and vasculogenesis in Flk-1 deficient mice. Nature 376 (1995) 62-66
34. Shi Q., Rafii S., Wu M.H., et al. Evidence for circulating bone marrow-derived endothelial cells. Blood 92 (1998) 362-367
35. Shintani S., Murohara T., Ikeda H., et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 103 (2001) 2776-2779
36. Stamm C., Kleine H.D., Choi Y.H., et al. Intramyocardial delivery of CD133+ bone marrow cells and coronary artery bypass grafting for chronic ischemic heart disease: safety and efficacy studies. J Thorac Cardiovasc Surg 133 (2007) 717-725
37. Stamm C., Westphal B., Kleine H.D., et al. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet 361 (2003) 45-46
38. Taguchi A., Soma T., Tanaka H., et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest 114 (2004) 330-338
39. Takahashi T., Kalka C., Masuda H., et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5 (1999) 434-438
40. Tateishi-Yuyama E., Matsubara H., Murohara T., et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360 (2002) 427-435
41. Tateno K., Minamino T., Toko H., et al. Critical roles of muscle-secreted angiogenic factors in therapeutic neovascularization. Circ Res 98 (2006) 1194-1202
42. Vasa M., Fichtlscherer S., Adler K., et al. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103 (2001) 2885-2890
43. Weiss M., and Orkin S.H. In vitro differentiation of murine embryonic stem cells: new approaches to old problems. J Clin Invest 97 (1996) 591-595
44. Yamaguchi J., Kusano K.F., Masuo O., et al. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107 (2003) 1322-1328
45. Yoon Y.S., Park J.S., Tkebuchava T., et al. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 109 (2004) 3154-3157
46. Zohlnhofer D., Ott I., Mehilli J., et al. Stem cell mobilization by granulocyte colony-stimulating factor in patients with acute myocardial infarction: a randomized controlled trial. JAMA 295 (2006) 1003-1010